PLASMA PROTEINS 1

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

TRANSFER OF THYROXINE RETINOL

Prealbumin(Transthyretin)

Vit. A and Thyroxine

Prealbumin(Transthyretin)

Prealbumin(Transthyretin) WHAT VITAMIN

Vit. A

INDICATOR of nutritional status

Malnutrition

Prealbumin(Transthyretin) landmark OF?

CSF

CSF landmark

Prealbumin(Transthyretin)

SEEN USING HIGH RESOLUTION ELECTROPHORESIS FOR IDENTIFICATION

Prealbumin(Transthyretin)

Prealbumin(Transthyretin) INCREASED / DECREASED alcoholism

INCREASED

Prealbumin(Transthyretin) INCREASED / DECREASED chronic renal failure

INCREASED

Prealbumin(Transthyretin) INCREASED / DECREASED steroid treatment

INCREASED

Prealbumin(Transthyretin) INCREASED / DECREASED poor nutrition

DECREASED

Prealbumin(Transthyretin) INCREASED / DECREASED Hepatic damage

DECREASED

Prealbumin(Transthyretin) INCREASED / DECREASED tissue necrosis

DECREASED

Prealbumin(Transthyretin) INCREASED / DECREASED Inflammatory response

DECREASED

Albumin IS ________ concentration

HIGHEST

IS HIGHEST concentration

Albumin

General TRANSPORT protein

Albumin

maintains OSMOTIC pressure

Albumin

IT RESIST PH CHANGES

Albumin

Negative APR ARE

Albumin TRANSFERRIN TRANSTHYRETIN

SENSITIVE AND SPECIFIC MARKER OF ALBUMIN

cystic fibrosis

hereditary absence of albumin

Analbuminemia

two albumin bands

Bisalbuminemia

most widely used methods for determining albumin

Dye binding

Acid sol’n + (-) albumin ฀ (+) albumin + ____________ dye = Dye absorbance

ANION

MOST COMMONLY USED dye IN Albumin

Bromcresol Green (BCG)

cause falsely low result IN Albumin

PENICILLIN

MOST SPECIFIC DYE IN ALBUMIN

Bromcresol Purple

– nonspecific DYE IN ALBUMIN

Methyl orange

low sensitivity, more specific to albumin

HABA- 2- (4' -hydroxyazobenzene) benzoic acid

When albumin is present in ascites, serum albumin is DECREASED

DECREASED

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism = Severe Dehydration

Increased Albumin

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism = .Prolonged tourniquet application

Increased Albumin

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism =Chronic Liver Disease

Decreased Albumin: Low Synthesis

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism =.Malabsorption

Decreased Albumin: Low Synthesis

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism =Malnutrition

Decreased Albumin: Low Synthesis

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism =Nephrotic syndrome

Decreased Albumin: Increased Loss

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism =Massive burns & Exfoliative dermatitis

Decreased Albumin: Increased Loss

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism =.Protein-Losing Enteropathy

Decreased Albumin: Increased Loss

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism =Orthosthatic Proteinuria

Decreased Albumin: Increased Loss

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism =malignancy

Decreased Albumin: Increased Catabolism

Increased Albumin Decreased Albumin: Low Synthesis Decreased Albumin: Increased Loss Decreased Albumin: Increased Catabolism = thyrotoxicosis

Decreased Albumin: Increased Catabolism

a1 – antitrypsin (AAT) IS PREDOMINANT IN

Alpha 1 Region

major inhibitor of protease activity

a1 – antitrypsin (AAT)

FIRSTMORNING URINE PROTEIN INDICATOR

2 HR STANDING URINE SAMPLE PROTEIN INDICATOR

Neautralize trypsin – like enzymes (elastase)

a1 – antitrypsin (AAT

WHAT DSE IF ELASTIN + ELASTASE

PULMONARY EMPHYSEMA

DEFICIENT IN ELASTASE

PULMONARY EMPHYSEMA

WHAT ORGAN PRODUCES ELASTASE

LIVER

DEFECTIVE ELASTASE

LIVER CIRRHOSIS

PULMONARY EMPHYSEMA AND LIVER CIRRHOSIS IN SERUM ELECTROPHORESIS PATTERN

FLAT CURVE IN ALPHA 1

Synthesized in the developing embryo and fetus and decrease after birth

a1-fetoprotein (AFP)

is measured between 15 and 20 weeks of gestation and is reported as multiples of the median (MoM).

Maternal serum AFP

Maternal serum AFP is measured between ? weeks of gestation and is reported as multiples of the median (MoM).

15 and 20 weeks

Maternal serum AFP is measured between 15 and 20 weeks of gestation and is reported as ?

multiples of the median (MoM).

a1-fetoprotein (AFP) Sample

Maternal serum

a1-fetoprotein (AFP) Binds

Estradiol

Binds Estradiol

a1-fetoprotein (AFP)

a1-fetoprotein (AFP) tumor marker

HEPATIC AND GONADAL CANCER

Neural tube defect and Down syndrome

a1-fetoprotein (AFP)

a major plasma glycoprotein, is negatively charged even in acid solutions

a1- acid glycoprotein/orosomucoid(AAG)

a1- acid glycoprotein/orosomucoid(AAG) Similar to __________________ in their amino acid sequence

IMMUNOGLOBULIN

Similar to IMMUNOGLOBULIN in their amino acid sequence

a1- acid glycoprotein/orosomucoid(AAG)

a1- acid glycoprotein/orosomucoid(AAG) greatest affinity for ______________

PROGESTERONE

greatest affinity for PROGESTERONE

a1- acid glycoprotein/orosomucoid(AAG)

AAG binds ? (cardioactive drug)

quinidine

THIS binds quinidine (cardioactive drug)

AAG

neonatal bacterial infection

a1- acid glycoprotein/orosomucoid(AAG)

Increased in:/ acute-phase reactant

a1- acid glycoprotein/orosomucoid(AAG)

Decreased: Nephrotic syndrome

a1- acid glycoprotein/orosomucoid(AAG)

a1- acid glycoprotein/orosomucoid(AAG) INCREASED/ DECREASED ? acute-phase reactant

Increased

a1- acid glycoprotein/orosomucoid(AAG) INCREASED/ DECREASED ? Nephrotic syndrome

Decreased

IT IS PART OF AMYLOID

a1 – antichymotrypsin (a1-x)

Acute phase reactant that Inhibits: Cathepsin G, Pancreatic Elastase, mast Cell chymase, and Chymotrypsi

a1 – antichymotrypsin (a1-x)

a1 – antichymotrypsin (a1-x) DISEASE ASOOCIATED

alzheimer’s disease

binds and inactivates prostate – specific antigen (PSA)

a1 – antichymotrypsin (a1-x)

MAJOR FORM OF TSA IN THE BLOOD

PSA

Serine protease inhibtors

Inter-α-Trypsin Inhibitor

Two precursors: Light chain and two heavy chains

Inter-α-Trypsin Inhibitor

Inter-α-Trypsin Inhibitor Two precursors:

Light chain and two heavy chains

Inter-α-Trypsin Inhibitor Has important role in ________ and ________

inflammation and carcinogenisis

Has important role in inflammation and carcinogenisis

Inter-α-Trypsin Inhibitor

Gc-Globulin Major Carrier of

Vitamin D

Major Carrier of Vitamin D

Gc-Globulin

Gc-Globulin Important for _____ formation

BONE

Important for BONE formation

Gc-Globulin

Carries Fatty acid and ENDOTOXIN

Gc-Globulin (Group-Specific Component; Vitamin D–Binding Protein)

Gc-Globulin Binds?

Protein

v. Co-chemotactic factor vi.Increase: 3rd trimester of pregnancy vii.Low level: protein losing enterophathy and liver disea

Gc-Globulin (Group-Specific Component; Vitamin D–Binding Protein)

protein with enzymatic activity

ceruloplasmin

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前